Matsumoto M, Tadenuma T, Nakamura K, Kume H, Imai T, Kihara R, Watanabe M, Benno Y. (2000) Effect of Bifidobacterium lactis LKM 512 yoghurt on fecal microflora in middle to old aged persons. Microbial Ecol. Health Dis. 12: 77-80.


松本光晴, 今井哲哉, 廣中貴弘, 久米仁司, 渡辺正利, 辨野義己.（2000）
Bifidobacterium lactis LKM512株含有ヨーグルトのヒト糞便菌叢および便性改善に及ぼす影響. 腸内細菌学雑誌 14: 97-102.


Matsumoto M, Ohishi H, Benno Y. (2001) Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol. Med. Microbiol. 31: 181-186.


Matsumoto M, Ohishi H, Kakizoe K, Benno Y. (2004) Faecal microbiota and secretory immunoglobulin A levels in adult patients with atopic dermatitis. Microbial Ecol. Health Dis. 16: 13-17.


Matsumoto M, Benno Y. (2004) Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat. Res. 568: 147-153.


Matsumoto M, Sakamoto M, Hayashi H, Benno Y. (2005) Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J. Microbiol. Methods 61: 305-319.


Bakir MA, Kitahara M, Sakamoto M, Matsumoto M, Benno Y. (2005) Bacteroides intestinalis sp. nov., isolated from human faeces. Int. J. Sys. Evol. Microbiol. 56: 151-154.


Bakir MA, Kitahara M, Sakamoto M, Matsumoto M, Benno Y. (2005) Bacteroides finegoldii sp. nov., isolated from human faeces. Int. J. Sys. Evol. Microbiol. 56: 931-935.


Bakir MA, Kitahara M, Sakamoto M, Matsumoto M, Benno Y. (2006)　Bacteroides dorei sp. nov., isolated 1 from human faeces. Int. J. Sys. Evol. Microbiol.56: 1639-43.


Matsumoto M, Benno Y. (2007) The relationship between microbiota and polyamine concentration in human intestine: a pilot study. Microbiol. Immunol.51: 25-35.


Matsumoto M, Kakizoe K, Benno Y. (2007) Comparison of fecal microbiota and polyamine concentration in adult patients with intractable atopic dermatitis and healthy adults. Microbiol. Immunol. 51: 37-46.


Matsumoto M, Aranami A, Ishige A, Watanabe K, Benno Y. (2007) LKM512 yogurt consumption improves the intestinal environment and induces the Th1-type cytokine in adult patients with intractable atopic dermatitis. Clin. Exp. Allergy 37: 358-370.


Matsumoto M, Hara K, Benno Y. (2007) The influence of the immunostimulation by bacterial cell components derived from altered large intestinal microbiota on probiotic anti-inflammatory benefits. FEMS Immunol. Med. Microbiol. 49: 387-90.


Matsumoto M, Sakamoto M, Benno Y. (2009) Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt. Microbiol. Immunol. 53: 421-32.


Jin JS, Touyama M, Kibe R, Tanaka Y, Benno Y, Kobayashi T, Shimakawa M, Maruo T, Toda T, Matsuda I, Tagami H, Matsumoto M, Seo G, Chonan O, Benno Y. (2013) Analysis of the human intestinal microbiota from 92 volunteers after ingestion of identical meals. Benef. Microbes 4: 187-93. doi: 10.3920/BM2012.0045


Kobayashi T, Jin J-S, Kibe R, Touyama M, Touyama Tanaka, Y, Benno Y, Fujiwara K, Shimakawa M, Maruo T, Toda T, Matsuda I, Tagami H, Matsumoto M, Seo G, Sato N, Chounan O, and Benno Y. (2013) Identification of human intestinal microbiota of 92 men by data mining for 5 characteristics, i.e., age, BMI, smoking habit, cessation period of previous smokers and drinking habit. Bioscience of Microbiota, Food and Health 32: 129–137.


Matsumoto M, Ebata T, Hirooka J, Hosoya R, Inoue N, Itami S, Tsuji K, Yaginuma T, Muramatsu K, Nakamura A, Fujita A, Nagakura T. (2014) Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann Allergy Asthma Immunol.　113: 209-216.


Murakami H, Shimomura Y, Matsumoto M, Lane GJ, Yamataka A, Okawada M. (2015) Intestinal microbiota in neonates requiring urgent surgery: assessing the role of probiotics using fecal DNA sequencing. Pediatric Surgery International　32:37-43


Matsumoto M, Kitada Y., Shimomura Y., Naito Y. (2017) Bifidobacterium animalis subsp. lactis LKM512 reduces levels of intestinal trimethylamine produced by intestinal microbiota in healthy volunteers: a double-blind, placebo-controlled study. J Functional Food 36: 94–10.
（ 悪玉コレステロール値等が正常範囲上限域の健常成人（動脈硬化予備軍）を対象に、ビフィズス菌LKM512を摂取する臨床試験の結果、LKM512摂取群でアテローム性動脈硬化の危険因子の前駆体である腸内のトリメチルアミン濃度が対照群より低くなったことを見出しました。）


Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J, Umezawa S, Uchiyama S, Matsumoto M, Nakajima A. (2018) Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut doi: 10.1136/gutjnl-2018-316661
（大腸癌患者の大腸癌組織と唾液のフソバクテリウム・ヌクレアタムを分離し、菌株レベルで同定した結果、大腸癌と唾液で同一菌株が存在することを確認しました。この結果は、大腸癌の原因菌が口腔内で棲息している可能性を強く示唆しており、大腸癌の予防や治療に関する研究分野では大きな意義を持つ発見となりました）